Sabine H.
- Country
- Germany
- Department
- Klinik für Frauenheilkunde und Geburtshilfe
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Palazestrant and Ribociclib versus Letrozole and Ribociclib for First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Phase 2 Study of ACR-368 and Gemcitabine in Subjects with Endometrial Cancer
Data & Insights
Has run more than one trial at 232 of 490 partner sites.
Specializations
Breast Cancer Research
Specializes in early-stage breast cancer treatment, with particular focus on post-neoadjuvant therapy approaches. Investigates genomics-guided treatment strategies for high-risk cases.
- Biomarker-guided therapy
- Systemic adjuvant treatments
- Neoadjuvant therapy optimization
Explores personalized treatment pathways following initial therapy and surgery.
Gynecologic Malignancies
Conducts research in advanced gynecologic cancers, including cervical, ovarian, and endometrial cancers. Focuses on novel therapeutic approaches for these conditions.
- Cervical cancer treatments
- Ovarian cancer therapies
- Endometrial cancer management
Evaluates innovative treatment options for patients with advanced or recurrent disease.
Precision Oncology
Specializes in molecular-based treatment approaches for gynecologic cancers, with emphasis on biomarker-driven therapy selection.
- Molecular profiling
- Targeted therapeutics
- Treatment stratification
Investigates personalized treatment strategies based on specific molecular features of cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.